Skip to main content

Table 3 Comparison of survey and NCR data (10-year prevalence) for rare and common cancer patients

From: Differences in health care experiences between rare cancer and common cancer patients: results from a national cross-sectional survey

 

Rare cancer

Common cancer

Survey

NCR

Survey

NCR

Age in years, mean

61

58

63

65

Gender, %

 Male

39%

47%

33%

48%

 Female

61%

53%

67%

52%

Type of cancer, %

 Sarcomas

12%

8%

0%

0%

 Female genital organs and breast cancer

15%

20%

43%

26%

 Male genital organ and urological cancer

4%

10%

19%

22%

 Neuroendocrine tumors

2%

7%

0%

0%

 Cancer of digestive tract

15%

6%

19%

17%

Cancer of endocrine organs

5%

5%

0%

0%

 Cancer of head and neck

8%

16%

0%

0%

 Thoracic cancer

2%

2%

7%

6%

 Melanoma of skin and eye

0%

3%

4%

24%

 Cancer of central nervous system

3%

5%

0%

0%

 Hematological cancer

37%

18%

9%

7%

Number of (types of) treatmenta, %

 No treatment

3%

4%

1%

6%

 1 type of treatment

31%

46%

25%

40%

 2 types of treatment

36%

28%

31%

30%

 > 2 types of treatment

29%

22%

43%

24%

Hospital of diagnosis, %

 Academic or cancer-specialized hospital

27%

17%

13%

8%

 Top-clinical hospital

45%

48%

48%

51%

 General hospital

29%

36%

39%

41%

Hospital of treatment, %

 Academic or cancer-specialized hospital

56%

43%

25%

12%

 Top-clinical hospital

30%

37%

45%

51%

 General hospital

14%

20%

30%

37%

Diagnosis and treatment in one hospital, %

 Yes

33%

51%

42%

64%

 No

67%

49%

59%

36%

Number of hospitals patients were treated in, %

 1

60%

80%

57%

74%

 ≥ 2

40%

20%

43%

26%

  1. a Types of treatment include surgery, radiation, chemotherapy, hormonal therapy, targeted therapy, stem cell transplantation, active surveillance and wait-and-see